Publicação: Angiotensin II AT(1) receptor mutants expressed in CHO cells caused morphological change and inhibition of cell growth
dc.contributor.author | Correa, SAA | |
dc.contributor.author | Pacheco, NAS | |
dc.contributor.author | Costa-Neto, Claudio Miguel da [UNESP] | |
dc.contributor.author | Oliveira, L. | |
dc.contributor.author | Pesquero, J. B. | |
dc.contributor.author | Han, S. W. | |
dc.contributor.author | Paiva, ACM | |
dc.contributor.author | Shimuta, S. I. | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.date.accessioned | 2015-03-18T15:54:02Z | |
dc.date.available | 2015-03-18T15:54:02Z | |
dc.date.issued | 2005-11-15 | |
dc.description.abstract | To assess the importance of the leucine residues in positions 262 and 265 of the angiotensin AT, receptor for signaling pathways and receptor expression and regulation, we compared the properties of CHO cells transfected with the wild type or the L262D or L265D receptor point mutants. It was found that the two mutants significantly increased the basal intracellular cyclic AMP (cAMP) formation in an agonist-independent mode. The morphology transformation of CHO cells was correlated with the increased cAMP formation, since forskolin, a direct activator of adenylate cyclase mimicked this effect on WT-expressing CHO cells. DNA synthesis was found to be inhibited in these cell lines, indicating that cAMP may also have determined the inhibitory effect on cell growth, in addition to the cell transformation from a tumorigenic to a non-tumorigenic phenotype. However a role for an increased Ca2(+) influx induced by the mutants in non-stimulated cells cannot be ruled out since this ion also was shown to cause transformed cells to regain the morphology and growth regulation. (c) 2005 Elsevier B.V. All rights reserved. | en |
dc.description.affiliation | Univ Fed Sao Paulo, Dept Biophys, Escola Paulista Med, BR-04023062 Sao Paulo, Brazil | |
dc.description.affiliation | Sao Paulo State Univ, Med Sch Ribeirao Preto, BR-14049900 Sao Paulo, Brazil | |
dc.description.affiliationUnesp | Sao Paulo State Univ, Med Sch Ribeirao Preto, BR-14049900 Sao Paulo, Brazil | |
dc.format.extent | 18-22 | |
dc.identifier | http://dx.doi.org/10.1016/j.regpep.2005.05.005 | |
dc.identifier.citation | Regulatory Peptides. Amsterdam: Elsevier Science Bv, v. 131, n. 1-3, p. 18-22, 2005. | |
dc.identifier.doi | 10.1016/j.regpep.2005.05.005 | |
dc.identifier.issn | 0167-0115 | |
dc.identifier.uri | http://hdl.handle.net/11449/116730 | |
dc.identifier.wos | WOS:000232709100003 | |
dc.language.iso | eng | |
dc.publisher | Elsevier B.V. | |
dc.relation.ispartof | Regulatory Peptides | |
dc.relation.ispartofsjr | 0,512 | |
dc.rights.accessRights | Acesso restrito | pt |
dc.source | Web of Science | |
dc.subject | AT(1) receptor | en |
dc.subject | mutagenesis | en |
dc.subject | cyclic AMP | en |
dc.subject | Ca+2 signaling | en |
dc.subject | cell proliferation | en |
dc.subject | morphology regulation | en |
dc.title | Angiotensin II AT(1) receptor mutants expressed in CHO cells caused morphological change and inhibition of cell growth | en |
dc.type | Artigo | pt |
dcterms.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dcterms.rightsHolder | Elsevier B.V. | |
dspace.entity.type | Publication | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu | pt |